PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the, Department of Acute Medicine, University College Hospital, Bloomsbury, London, UK.\', \'Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warszawa, Poland.\', \'Department of Coronary Artery Disease and Cardiac Rehabilitation, Cardinal Stefan Wyszynski Institute of Cardiology, Warszawa, Poland.\', \'Department of Critical Care, Lewisham and Greenwich NHS Trust, London, UK.\', \'Department of Acute Medicine, Newham University Hospital NHS Trust, Newham University Hospital, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/joim.13202
?:doi
?:hasPublicationType
?:journal
  • Journal of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 33210357
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.042
?:rankingScore_hIndex
  • 140
is ?:relation_isRelatedTo_publication of
?:title
  • ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all